Preterms Clinical Trial
Official title:
Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction in Preterm Infants With Gestational Age <30 Weeks
Observational study of preterm infant with a gestational age < 30 weeks born between 2017-2023 in Neonatal Care Unit in Gregorio Marañon Hospital (Madrid, Spain). We use a new ultrasonographic prognostic scale of periventricular hemorrhagic infarction for neurodevelopmental outcome at age 2 years.
Status | Recruiting |
Enrollment | 360 |
Est. completion date | October 1, 2025 |
Est. primary completion date | July 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Gestacional Age < 30 weeks Exclusion Criteria: - Brain malformation - Genetic syndrome - Metabolic disorders - Chromosomal abnormality - None cranial ultrasound |
Country | Name | City | State |
---|---|---|---|
Spain | Gregorio Marañon Hospital | Madrid |
Lead Sponsor | Collaborator |
---|---|
Manuel Sanchez Luna |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Periventricular Hemorrhagic Infarction | Yes or no | first month | |
Primary | Characteristic Sonographic | first month | ||
Primary | Neurodevelopmental outcome at age 2 years | first month | ||
Secondary | Medical records | first month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02384655 -
Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content
|
Phase 1/Phase 2 |